Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing ...

Moderna (MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...

An AI collaboration boosted the company behind the largest U.S. cloud service on Monday, Nov. 3, 2025, while shares of the ...

With 4% GDP growth, North Africa leads Africa’s economy, powered by Egypt’s reforms, Morocco’s FDI inflows, and cross-border ...

CAMBRIDGE, MA / ACCESS Newswire / / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a ...

Thank you, operator. Good morning and good afternoon, everybody, and thank you for joining BioNTech's Third Quarter 2025 Earnings Call. As a reminder, the slides we'll use during the call and the ...

BP reports Q3 earnings soon amid strategic shifts to oil & gas. Learn why analysts see turnaround potential and value for ...

The major stock indexes were mixed on Monday, at the outset of another busy week of quarterly earnings reports and the release of key private sector employment data.

The Cambridge Index fell 338.31 points or 1.3% to close at 26,348.5, as five out of the top ten index heavyweights posted weekly losses in their share price. Raspberry PI Holdings, down 1.8%, ...

Cipher Mining Inc. (NASDAQ:CIFR) stock soared 15% Monday after the company announced a significant $5.5 billion, 15-year lease agreement with Amazon Web Services ...

Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stagesDemons ...